MIR100HG and cancer: In turn, GATA6 binds to GATA-binding sites in the promoter region of MIR100HG and represses the expression of MIR100HG. These regulatory networks provide a molecular basis for understanding the complexity of cetuximab resistance and highlight the importance of such networks for successful cancer therapy [33].